Robert Lorne Hopfner, Director at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds 1.57M shares in Inozyme Pharma (Ticker: INZY), holds 2.27M shares in Rallybio (Ticker: RLYB). Most recently, Robert Lorne Hopfner ― shares of Hyperion Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Robert Lorne Hopfner?
The percentage of profitable transactions made by Robert Lorne Hopfner is 50%.
What is the average return per transaction made by Robert Lorne Hopfner?
The average return per transaction made by Robert Lorne Hopfner is 6.50%.
What stocks does Robert Lorne Hopfner hold?
Robert Lorne Hopfner holds: HPTX, PCVX, INZY, RLYB stocks.
What was Robert Lorne Hopfner’s latest transaction?
Robert Lorne Hopfner latest transaction was an Uninformative Buy of ―.
What was Robert Lorne Hopfner's most profitable transaction?
Robert Lorne Hopfner’s most profitable transaction was an Informative Buy of INZY stock on March 30, 2023. The return on the trade was 63.30%.
What is Robert Lorne Hopfner's role in Hyperion Therapeutics?
Robert Lorne Hopfner's role in Hyperion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.